112 related articles for article (PubMed ID: 2675195)
41. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
Costall B; Eniojukan JF; Naylor RJ
Eur J Pharmacol; 1983 Dec; 96(3-4):201-10. PubMed ID: 6426976
[TBL] [Abstract][Full Text] [Related]
42. Desenkephalin-gamma-endorphin is an antagonist of the hyperactivity response induced by infusion of dopamine into the nucleus accumbens of rat and ventral striatum of marmoset.
Costall B; Domeney AM; Naylor RJ
Neuropharmacology; 1989 Nov; 28(11):1223-9. PubMed ID: 2574424
[TBL] [Abstract][Full Text] [Related]
43. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats.
Ladurelle N; Keller G; Blommaert A; Roques BP; Daugé V
Eur J Neurosci; 1997 Sep; 9(9):1804-14. PubMed ID: 9383203
[TBL] [Abstract][Full Text] [Related]
44. Effects of locally applied dopamine to the nucleus accumbens on the motor activity of normal rats and following alpha-methyltyrosine or reserpine.
Wachtel H; Ahlenius S; Andén NE
Psychopharmacology (Berl); 1979 Jun; 63(3):203-6. PubMed ID: 113804
[TBL] [Abstract][Full Text] [Related]
45. Effects of chronic dietary lithium on behavioral indices of dopamine denervation supersensitivity in the rat.
Swerdlow NR; Lee D; Koob GF; Vaccarino FJ
J Pharmacol Exp Ther; 1985 Nov; 235(2):324-9. PubMed ID: 3932641
[TBL] [Abstract][Full Text] [Related]
46. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
Gong W; Neill DB; Lynn M; Justice JB
Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
[TBL] [Abstract][Full Text] [Related]
47. Substance P modulation of the mesolimbic dopamine system.
Kalivas P
Prog Clin Biol Res; 1985; 192():403-8. PubMed ID: 2417255
[TBL] [Abstract][Full Text] [Related]
48. Do forebrain structures compete for behavioral expression? Evidence from amphetamine-induced behavior, microdialysis, and caudate-accumbens lesions in medial frontal cortex damaged rats.
Whishaw IQ; Fiorino D; Mittleman G; Castañeda E
Brain Res; 1992 Mar; 576(1):1-11. PubMed ID: 1381257
[TBL] [Abstract][Full Text] [Related]
49. GABA(A) agents injected into the ventral pallidum differentially affect dopaminergic pivoting and cholinergic circling elicited from the shell of the nucleus accumbens.
Kitamura M; Ikeda H; Koshikawa N; Cools AR
Neuroscience; 2001; 104(1):117-27. PubMed ID: 11311536
[TBL] [Abstract][Full Text] [Related]
50. Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1/D2 agonists.
Ikemoto S
Neuroscience; 2002; 113(4):939-55. PubMed ID: 12182899
[TBL] [Abstract][Full Text] [Related]
51. Cholecystokinin combined with serotonin in the hypothalamus limits accumbens dopamine release while increasing acetylcholine: a possible satiation mechanism.
Helm KA; Rada P; Hoebel BG
Brain Res; 2003 Feb; 963(1-2):290-7. PubMed ID: 12560135
[TBL] [Abstract][Full Text] [Related]
52. Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanisms.
Ferraro L; O'Connor WT; Li XM; Rimondini R; Beani L; Ungerstedt U; Fuxe K; Tanganelli S
Neuroscience; 1996 Aug; 73(4):941-50. PubMed ID: 8809813
[TBL] [Abstract][Full Text] [Related]
53. Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine.
Essman WD; McGonigle P; Lucki I
Psychopharmacology (Berl); 1993; 112(2-3):233-41. PubMed ID: 7871025
[TBL] [Abstract][Full Text] [Related]
54. Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat.
Blaha CD; Phillips AG; Lane RF
Regul Pept; 1987 Jun; 17(6):301-10. PubMed ID: 3602473
[TBL] [Abstract][Full Text] [Related]
55. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
Pierce RC; Kalivas PW
J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
[TBL] [Abstract][Full Text] [Related]
56. Balance of glutamate and dopamine in the nucleus accumbens modulates self-stimulation behavior after injection of cholecystokinin and neurotensin in the rat brain.
Heidbreder C; Gewiss M; De Mot B; Mertens I; De Witte P
Peptides; 1992; 13(3):441-9. PubMed ID: 1523160
[TBL] [Abstract][Full Text] [Related]
57. Increased sensitivity to amphetamine and reward-related stimuli following social isolation in rats: possible disruption of dopamine-dependent mechanisms of the nucleus accumbens.
Jones GH; Marsden CA; Robbins TW
Psychopharmacology (Berl); 1990; 102(3):364-72. PubMed ID: 2251333
[TBL] [Abstract][Full Text] [Related]
58. Passive avoidance in rats: disruption by dopamine applied to the nucleus accumbens.
Bracs PU; Gregory P; Jackson DM
Psychopharmacology (Berl); 1984; 83(1):70-5. PubMed ID: 6429703
[TBL] [Abstract][Full Text] [Related]
59. Locomotor bias produced by intra-accumbens injection of dopamine agonists and antagonists.
Messier C; Mrabet O; Destrade C
Pharmacol Biochem Behav; 1992 Jan; 41(1):177-82. PubMed ID: 1347172
[TBL] [Abstract][Full Text] [Related]
60. Cholecystokinin modulates mesolimbic dopaminergic influences on male rat copulatory behavior.
Markowski VP; Hull EM
Brain Res; 1995 Nov; 699(2):266-74. PubMed ID: 8616630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
